首頁 › 子宮內膜癌 › 路易斯安那 › New Orleans
New Orleans, LA 的 子宮內膜癌 臨床試驗
9 項針對 子宮內膜癌 的研究正在 New Orleans（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
招募中3 期
- University Medical Center New Orleans, New Orleans
- West Jefferson Medical Center, Marrero · 距離 4 英里
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
招募中2 期
- Ochsner Medical Center Jefferson, New Orleans
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
招募中觀察性研究
- Ochsner Clinic Foundation, New Orleans
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
招募中2 期
- University Medical Center New Orleans, New Orleans
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
招募中觀察性研究
- Tulane Cancer Center, New Orleans
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
招募中2 期
- LSU Health Sciences, New Orleans
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
招募中1/2 期
- Louisiana State University Health Sciences Center, New Orleans
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
招募中2 期
- Ochsner MD Anderson Cancer Center, New Orleans
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, New Orleans
其他城市的 子宮內膜癌 試驗
- Houston, TX68 項研究
- New York City, NY52 項研究
- Boston, MA50 項研究
- Arlington, VA39 項研究
- Nashville, TN38 項研究
- Los Angeles, CA34 項研究
- St. Louis, MO29 項研究
- Philadelphia, PA28 項研究
- San Antonio, TX27 項研究
- Columbus, OH25 項研究
- Chicago, IL25 項研究
- Oklahoma City, OK25 項研究
New Orleans 的其他研究
- 癌症（所有類型）12 項研究
- 卵巢癌12 項研究
- 乳癌11 項研究
- 前列腺癌10 項研究
- 轉移性癌症9 項研究
- 肺癌9 項研究
- 非小細胞肺癌9 項研究
- 心血管疾病9 項研究
- 肥胖症8 項研究
- 脂肪性肝病8 項研究
- 大腸直腸癌8 項研究
- 心房顫動8 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。